PATENT CLAIM ANALYSIS

Application Number: 15777529
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "215000"]

Abstract:
The present disclosure relates to a use of a phloroglucinol-based compound and its salt for preventing and treating Alzheimer's disease. The pharmaceutical composition for preventing or treating Alzheimer's disease of the present disclosure fundamentally suppresses the cause of β-amyloid formation, thereby exerting a remarkable effect of allowing ultimate treatment of Alzheimer's disease. The present disclosure provides the use of the single substance, which has been isolated from  Dryopteris crassirhizoma  and identified, for preventing or treating Alzheimer's disease for the first time.

Claim (Index 3):
The pharmaceutical composition for preventing or treating Alzheimer's disease according to  claim 1 , wherein the pharmaceutical composition comprises butyrylphloroglucinol as an active ingredient.

Metadata:
- Claim Count in Document: 22.0
- Percentile: 93.0
- Lexical Diversity: 1.82
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12607972', '14303622', '14036810', '14384641', '12942785']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.767251165437344
- 35 USC 102 Novelty (BERT): 0.5050446744421664
- Combined Prediction Score: 0.7410305163378262
- Mean Citation Score: 228.699178
- Max Citation Score: 263.6163
- Similarity Product: 195.1637259793103

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test